Released Aug 15, 2011, after the close
10-Q filed Aug 15, 2011, 46 days after period end · 0001144204-11-047352
Q2 2011 · 10-Q
Revenue—
Net Income-$6.96M-$6.96M N/M vs Q2 2010N/M vs Q1 2011
EPS Diluted-$0.97-$0.97 N/M vs Q2 2010N/M vs Q1 2011
Operating Income-$6,901,571N/M
Operating Cash Flowderived-$2,851,968—
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q2 2011 | Q2 2010 |
|---|---|---|
| Net Income | -$6.96M | -$2.13M |
| EPS Diluted | -$0.97 | -$4.76 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Assembly Biosciences, Inc. · CIK 1426800 · Engraved from SEC EDGAR